Gibson Christopher sold RXRX
September 25, 2025 · Form 4 insider transaction
Gibson Christopher sold 0 shares of Recursion Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as conversion of a derivative under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
0
Price
$0.00
Total value
N/A
InsiderGibson Christopher
Role—
SecurityClass B Common Stock
Transaction codeC: Conversion of a derivative
Transaction dateSeptember 25, 2025
Filing dateSeptember 26, 2025
Shares owned after5,253,034
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.; This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025.